Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: Results of a randomized controlled trial

Journal of Alzheimer's Disease

Volumn 26, Issue 3, 2011, Pages 495-505

  Wharton, Whitney ^a,b   Baker, Laura D ^c,d   Gleason, Carey E ^a,b   Dowling, Maritza ^a,b   Barnet, Jodi H ^a,b   Johnson, Sterling ^a,b   Carlsson, Cynthia ^a,b   Craft, Suzanne ^c,d   Asthana, Sanjay ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; clinical trial; cognition; estradiol; estrogen; hormone therapy; medroxyprogesterone; memory

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMANTIC MEMORY; SENSITIVITY ANALYSIS; SHORT COURSE THERAPY; TREATMENT OUTCOME; VAGINA BLEEDING; VISUAL MEMORY;

EID: 80053482654     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110341     Document Type: Article

References (75)

1. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 102, 19198-19203.
2. McEwen B, Alves S, Bulloch K, Weiland N (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48(7), 8-. S8-S15
3. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 279, 688-695.
4. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR (1999) Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24, 657-677.
5. Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR (2001) High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57, 605-612.
6. Henderson V, Paganini-Hill A, Emanuel C, Dunn M, Buckwalter J (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51,896-900.
7. Korf ES, White LR, Scheltens P, Launer LJ (2004) Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 44, 29-34.
8. Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88, 1337-1342.
9. HendersonVW(2010) Action of estrogens in the aging brain: Dementia and cognitive aging. Biochim Biophys Acta 1800, 1077-1078.
10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
11. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2959-2968.
12. Wharton W, Dowling M, Khosropour CM, Carlsson C, Asthana S, Gleason CE (2009) Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias. Maturitas 64, 182-187.
13. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
14. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
15. Henderson V (1997) Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 8, 343-351.
16. Honjo H, Ogino Y, Tanaka K, Urabe M, Kashiwagi T, Ishihara S, Okada H, Araki K, Fushiki S, Nakajima K, Hayashi K, Hayashi M, Sakaki T (1993) An effect of conjugated estrogen to cognitive impairment in women with senile dementia- Alzheimer's type: A placebo-controlled, double-blind study. J Jpn Menopause Soc 1, 167-171.
17. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC (2000) Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54, 2061-2066.
18. Modena MG, Sismondi P, MueckAO,Kuttenn F, Lignieres B, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR (2005) New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 52, 1-10
19. Garza-Meilandt A, Cantu RE, Claiborne BJ (2006) Estradiol's effects on learning and neuronal morphology vary with route of administration. Behav Neurosci 120, 905-916.
20. Scarabin P, Oger E, Plu-Bureau G, group obotEaTEs (2003) Differential association of oral and transdermal oestrogen replacement therapy with venous thromboembolism risk. Lancet 362, 428-432.
21. Birge S (1997) The role of estrogen in the treatment of Alzheimer's disease. Neurology 48, 36-. S36-S41.
22. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54, 295-301.
23. Honjo H,Tanaka K, KashiwagiT, UrabeM,Okada H, Hayashi M, Hayashi K (1995) Senile dementia-Alzheimer's type and estrogen. Horm Metab Res 27, 204-207.
24. Caldwell B, Watson R (1952) An evaluation of psychologic effects of sex hormone administration in agedwomen: Results after six months. J Gerontol 7, 228-244.
25. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283, 1007-1015.
26. Zhang Y, Luo G, Guo ZJ, Cui RY,Wang LQ, Zhou, CL (2006) Quantitative evaluation of the intervention al effect of estrogen on Alzheimer's disease. Chin J Clin Rehab 10, 37-91.
27. Valen-Sendstad A, Engedal K, Stray-Pedersen B, Strobel C, Barnett L, Meyer N, Nurminemi M. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone. Am J Geriatr Psychiatry 18, 11-20.
28. Hogervorst E, Yaffe K, Richards M, Huppert, FA (2009) Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev, D003799.
29. Asthana S, Baker L, Craft S, Lofgreen C,Avery E, Raskind M, Cherrier M, Wong M, Veith R, Plymate, S (1998) Estrogeninduced enhancement in memory in postmenopausal women with Alzheimer's disease. Neurobiol Aging 19, 748. Abstract # 748, page S178.
30. Hogervorst E, Yaffe K, Richards M, Huppert F (2002) Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev, CD003122.
31. Kawas C, Resnick S, Morrison A (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
32. Kantor H, Michael C, Shore H (1973) Estrogen for older women. Am J Obstet Gynecol 116, 115-118.
33. Caldwell B (1954) An evaluation of psychological effects of sex hormone administration in aged women. J Gerontol 9, 168-174.
34. Kaplan E, Goodglass H,Weintraub S (1983) The Boston Naming Test, Lea & Febiger, Philadelphia.
35. Wechsler D (1945) A standardized memory scale for clinical use. J Psychology 19, 87-95.
36. Corwin J, Bylsma F (1993) Translations of excerpts from Andre Rey's Psychological examination of traumatic encephalopathy and P.A. Osterrieth's The Complex Figure Copy Test. Clin Neuropsychologist 7, 3-15.
37. WechslerD(1987)Wechsler Memory Scale-Revised Manual, The Psychological Corporation. San Antonio, TX.
38. Spreen O, Strauss, E (1998) A compendium of neuropsychological tests, Oxford University Press, New York.
39. Buschke H (1973) Selective reminding for analysis of memory and learning. J Verb Learn Verb Behav 12, 543-550.
40. Dodrill C (1978) A neuropsychological battery for epilepsy. Epilepsia 19, 611-623.
41. Stroop J (1935) Studies of interference in serial verbal reactions. J Exp Psychology 18, 643-662.
42. McNair DM, Lorr M, Droppleman, LF (1981) POMS manual, EdITS. San Diego, CA.
43. Sherwin B (1988) Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affective Disord 14, 177-187.
44. Hosaka T, SugiyamaY(2003) Structured intervention in family caregivers of the demented elderly and changes in their immune function. Psychiatry Clin Neurosci 57, 147-151.
45. Studd J, PanayN(2004) Hormones and depression inwomen. Climacteric 7, 338-346.
46. Zweifel JE, O'BrienWH(1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22, 189-212.
47. Carlson LE, Sherwin BB (1998) Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 23, 583-603.
48. Kampen DL, Sherwin BB (1996) Estradiol is related to visual memory in healthy young men. Behav Neurosci 110, 613-617.
49. Albertazzi P, Natale V, Barbolini C, Teglio L, Di Micco R (2000) The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas 36, 223-229.
50. Smith YR, Giordani B, Lajiness-O'Neill R, Zubieta JK (2001) Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril 76, 1101-1107.
51. Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong L (2008) A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics. Clin Trials 5, 523-533.
52. Mathibe LJ (2007) Drop-out rates of cancer patients participating in longitudinal RCTs. Contemp Clin Trials 28, 340-342.
53. Touloumi G, Babiker AG, Pocock SJ, Darbyshire JH (2001) Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study. Stat Med 20, 3715-3728.
54. Kristman V, Manno M, Cote P (2004) Loss to follow-up in cohort studies: how much is too much?. Eur J Epidemiol 19, 751-760.
55. Lohr S (1999) Sampling: design and alanysis In Nonresponse, SL L, ed. Duxbury Press, Pacific Grove, pp. 255-287.
56. Altman DG (2000) Statistics in medical journals: some recent trends. Stat Med 19, 3275-3289.
57. Littell R MG, Stroup W, Wolfinger R (1996) SAS System for Mixed Models. Cary, NC.
58. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38, 963-974.
59. Knapp M, Knopman D, Solomon P, Pendlebury W, Davis C, Gracon S (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271, 985-991.
60. Gleason CE, Cholerton B, CarlssonCM,Johnson SC, Asthana S (2005) Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell Mol Life Sci 62, 299-312.
61. Hu L, Yue Y, Zuo PP, Jin ZY, Feng F, You H, Li ML, Ge QS (2006) Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner. Chin Med Sci J 21, 214-218.
62. Yue Y, Hu L, Tian QJ, Jiang JM, Dong YL, Jin ZY, Cheng YH, Hong X, Ge QS, Zuo PP (2007) Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes. Acta Pharmacol Sin 28, 1129-1135.
63. Bhavnani BR (2003) Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol 85, 473-482.
64. Stirone C, Boroujerdi A, Duckles SP, Krause DN (2005) Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67, 105-113.
65. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR (2000) Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87, 677-682.
66. Florian M, LuY, Angle M, Magder S (2004) Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 69, 637-645.
67. Watanabe Y, Littleton-Kearney MT, Traystman RJ, Hurn PD (2001) Estrogen restores postischemic pial microvascular dilation. Am J Physiol Heart Circ Physiol 281, H155-H160.
68. Grodstein F, Chen J, Pollen DA, Albert MS, Wilson RS, Folstein MF, Evans DA, Stampfer MJ (2000) Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 48, 746-752.
69. YaffeK, Lui L-Y, GradyD(2000) Cognitive decline inwomen in relation to non-protein bound oestradiol concentrations. Lancet 356, 708-712.
70. Bjorn I, Bixo M, Nojd KS, Nyberg S, Backstrom T (2000) Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 183, 1419-1426.
71. Kolber BJ, Muglia LJ (2009) Defining brain region-specific glucocorticoid action during stress by conditional gene disruption in mice. Brain Res 1293, 85-90.
72. Resnick SM, Espeland MA, AnY, Maki PM, Coker LH, Jackson R, Stefanick ML, Wallace R, Rapp SR (2009) Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 94, 4152-4161.
73. Faulkner DL, Young C, Hutchins D, McCollam JS (1998) Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database. Menopause 5, 226-229.
74. Ettinger B, Pressman A, Silver P (1999) Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 6, 282-289.
75. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ, 3rd (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69, 1074-1083.